Perrigo is one of the largest consumer health companies in the world. Since 2018, Perrigo divested its animal health and generic pharmaceuticals businesses to solely focus on consumer self-care. In North America (two thirds of total sales), the firm’s product mix is anchored in private-label consumer health goods, which are sold to major retailers like Walmart, Amazon, Costco, and CVS. Perrigo also plays in Europe, Australia, and parts of Asia where it primarily generates revenue through its national brands, including Compeed, Solpadeine, Coldrex, and ellaOne.
2013
8.4K+
LTM Revenue $4.4B
LTM EBITDA $734M
$6.5B
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
Perrigo has a last 12-month revenue of $4.4B and a last 12-month EBITDA of $734M.
In the most recent fiscal year, Perrigo achieved revenue of $4.4B and an EBITDA of $433M.
Perrigo expects next 12-month revenue of XXX   and NTM EBITDA of XXX
See Perrigo valuation multiples based on analyst estimatesFY 2023 | FY 2024 | FY 2025 | LTM | NTM | |
---|---|---|---|---|---|
Revenue | $4.7B | $4.4B | XXX | XXX | XXX |
Gross Profit | $1.5B | $1.7B | XXX | XXX | XXX |
Gross Margin | 31% | 38% | XXX | XXX | XXX |
EBITDA | $525M | $433M | XXX | XXX | XXX |
EBITDA Margin | 11% | 10% | XXX | XXX | XXX |
Net Profit | -$141M | -$12.7M | XXX | XXX | XXX |
Net Margin | -3% | 0% | XXX | XXX | XXX |
Net Debt | $3.5B | $3.3B | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of April 15, 2025, Perrigo's stock price is $25.
Perrigo has current market cap of $3.4B, and EV of $6.5B.
See Perrigo trading valuation dataEV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
---|---|---|---|---|---|---|
$6.5B | $3.4B | XXX | XXX | XXX | XXX | $2.69 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Sign UpAs of April 15, 2025, Perrigo has market cap of $3.4B and EV of $6.5B.
Perrigo's trades at 1.5x LTM EV/Revenue multiple, and 8.8x LTM EBITDA.
Analysts estimate Perrigo's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See valuation multiples for Perrigo and 10K+ public compsFY 2024 | FY 2025E | FY 2026E | FY 2027E | |
---|---|---|---|---|
EV | $6.5B | XXX | XXX | XXX |
EV/Revenue | 1.5x | XXX | XXX | XXX |
EV/EBITDA | 14.9x | XXX | XXX | XXX |
P/E | -19.9x | XXX | XXX | XXX |
P/E/Growth | n/a | XXX | XXX | XXX |
EV/FCF | 26.5x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Sign UpPerrigo's NTM/LTM revenue growth is 1%
Perrigo's revenue per employee for the last fiscal year averaged $0.5M, while opex per employee averaged $0.1M for the same period.
Over next 12 months, Perrigo's ratio of sales and marketing spend to revenue is estimated to be XXX , while its R&D spend to revenue to be XXX .
Analysts estimate Perrigo's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See operational valuation multiples for Perrigo and other 10K+ public compsFY 2024 | NTM | FY 2025E | FY 2026E | FY 2027E | |
---|---|---|---|---|---|
Revenue Growth | -6% | XXX | XXX | XXX | XXX |
EBITDA Margin | 10% | XXX | XXX | XXX | XXX |
EBITDA Growth | -18% | XXX | XXX | XXX | XXX |
Rule of 40 (SaaS-only) | 11% | XXX | XXX | XXX | XXX |
Revenue per Employee | $0.5M | XXX | XXX | XXX | XXX |
Opex per Employee | $0.1M | XXX | XXX | XXX | XXX |
S&M Expenses to Revenue | 15% | XXX | XXX | XXX | XXX |
G&A Expenses to Revenue | 11% | XXX | XXX | XXX | XXX |
R&D Expenses to Revenue | 3% | XXX | XXX | XXX | XXX |
Opex to Revenue | 28% | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
EV/Revenue | EV/EBITDA | |||||
---|---|---|---|---|---|---|
2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
Acme United | XXX | XXX | XXX | XXX | XXX | XXX |
EZZ Life Science | XXX | XXX | XXX | XXX | XXX | XXX |
Live Verdure | XXX | XXX | XXX | XXX | XXX | XXX |
Lavipharm | XXX | XXX | XXX | XXX | XXX | XXX |
Sarantis Group | XXX | XXX | XXX | XXX | XXX | XXX |
XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Perrigo acquired XXX companies to date.
Last acquisition by Perrigo was XXXXXXXX, XXXXX XXXXX XXXXXX . Perrigo acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiplesAcquired Company | EV | EV/Revenue | EV/EBITDA |
---|---|---|---|
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Sign UpWhen was Perrigo founded? | Perrigo was founded in 2013. |
Where is Perrigo headquartered? | Perrigo is headquartered in United States of America. |
How many employees does Perrigo have? | As of today, Perrigo has 8.4K+ employees. |
Who is the CEO of Perrigo? | Perrigo's CEO is Mr. Patrick Lockwood Taylor. |
Is Perrigo publicy listed? | Yes, Perrigo is a public company listed on NYS. |
What is the stock symbol of Perrigo? | Perrigo trades under PRGO ticker. |
When did Perrigo go public? | Perrigo went public in 1991. |
Who are competitors of Perrigo? | Similar companies to Perrigo include e.g. Acme United, EZZ Life Science, Live Verdure, Lavipharm. |
What is the current market cap of Perrigo? | Perrigo's current market cap is $3.4B |
What is the current revenue of Perrigo? | Perrigo's last 12-month revenue is $4.4B. |
What is the current EBITDA of Perrigo? | Perrigo's last 12-month EBITDA is $734M. |
What is the current EV/Revenue multiple of Perrigo? | Current revenue multiple of Perrigo is 1.5x. |
What is the current EV/EBITDA multiple of Perrigo? | Current EBITDA multiple of Perrigo is 8.8x. |
What is the current revenue growth of Perrigo? | Perrigo revenue growth between 2023 and 2024 was -6%. |
Is Perrigo profitable? | Yes, Perrigo is EBITDA-positive (as of the last 12 months). |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.